| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.48B | 22.57B | 23.38B | 23.18B | 29.49B | 19.67B |
| Gross Profit | 16.74B | 15.37B | 17.70B | 18.24B | 24.62B | 14.32B |
| EBITDA | 12.15B | 11.30B | 12.46B | 13.33B | 13.62B | 9.76B |
| Net Income | 5.50B | 4.98B | 6.40B | 7.59B | 7.76B | 4.66B |
Balance Sheet | ||||||
| Total Assets | 53.38B | 51.80B | 47.19B | 43.86B | 41.37B | 38.24B |
| Cash, Cash Equivalents and Short-Term Investments | 3.85B | 3.40B | 7.09B | 5.28B | 5.97B | 5.21B |
| Total Debt | 8.31B | 8.41B | 5.07B | 4.16B | 5.96B | 5.91B |
| Total Liabilities | 22.47B | 21.97B | 17.84B | 15.77B | 16.59B | 16.06B |
| Stockholders Equity | 30.91B | 29.83B | 29.35B | 28.09B | 24.78B | 22.18B |
Cash Flow | ||||||
| Free Cash Flow | 4.23B | 3.93B | 5.77B | 5.16B | 6.09B | 4.94B |
| Operating Cash Flow | 10.72B | 10.04B | 12.14B | 11.34B | 11.09B | 8.79B |
| Investing Cash Flow | -11.05B | -10.94B | -5.97B | -6.34B | -5.06B | -3.42B |
| Financing Cash Flow | -2.42B | -2.80B | -4.36B | -5.69B | -5.27B | -3.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $74.71B | 9.71 | 18.28% | 3.79% | 0.31% | -5.71% | |
73 Outperform | $35.16B | 6.40 | 14.34% | 1.17% | 50.77% | 800.70% | |
69 Neutral | $149.13B | 18.50 | 11.29% | 3.43% | 1.02% | -25.38% | |
69 Neutral | $57.06B | 65.10 | 14.78% | 2.64% | 1.96% | -18.06% | |
69 Neutral | $59.30B | 4.74 | 12.82% | 2.39% | -15.17% | -66.00% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
62 Neutral | $57.26B | 97.11 | 1.06% | 2.70% | 18.09% | -94.57% |